Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

NCT02851745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Left Ventricular Systolic Dysfunction

Interventions

DRUG: Linagliptin
DRUG: Placebo

Sponsor

Heart Care Foundation

Collaborators

[object Object]